OTCPharm Micoderil solution for outdoor. application 1% No. 1, 30 ml
Category
Antifungal
Scope of the drug
Dermatology
Manufacturer country
Russia
Way of introduction
Outwardly
Indications for the use of ICD-10
B35 Dermatophytosis
MikoderilВ®, solution for external use, 1% - an antifungal agent intended for external use, belonging to the class of allylamines.
Its active ingredient is naftifine.
The mechanism of action is associated with inhibition of squalene-2,3-epoxidase, which leads to a decrease in the formation of ergosterol, which is part of the cell wall of the fungus.
Naftifine, affecting squalene epoxidase, does not affect the cytochrome P-450 system.
Name ENG
Mikoderil
Clinical and pharmacological group
antifungal agent.
ATX code
D01AE22
Dosage
10 mg per ml
Structure
Composition for 1 ml:
Active ingredient: naftifine hydrochloride - 10.0 mg.
Excipients: propylene glycol - 50.0 mg, ethanol (ethyl alcohol 95%) - 400.0 mg, purified water - up to 1 ml.
Indications
- fungal infections of smooth skin and skin folds
- interdigital mycoses
- fungal infections of the nails
- skin candidiasis
- pityriasis versicolor
- dermatomycosis (with or without itching).
INN / Active ingredient
naftifine
Storage conditions and periods
Storage conditions At a temperature not exceeding 25 В° РЎ in original packaging (bottle in a cardboard box).
Keep out of the reach of children.
Shelf life 2 years.
Do not use after the expiration date printed on the package.
Specifications
Category
Antifungal
Scope of the drug
Dermatology
Manufacturer country
Russia
Way of introduction
Outwardly
Indications for the use of ICD-10
B35 Dermatophytosis
Shelf life after opening
1 year
Minimum humidity,%
25
Brand name
OTCPharm
Expiration date in days
720
The target audience
Adult
Package weight, g
thirty
Mode of application
:
Outwardly.
With dermatomycosis and candidiasis of the skin.
MicoderilВ®, spray for external use, 1% is applied once a day to the affected skin surface and adjacent areas after thorough cleaning and drying, capturing approximately 1 cm of healthy skin along the edges of the affected area.
Duration of treatment: with dermatomycosis - 2-4 weeks (if necessary - up to 8 weeks), with candidiasis - 4 weeks.
With nail lesions (onychomycosis).
The drug is used 2 times a day, the duration of treatment for onychomycosis is up to 6 months.
To prevent recurrence of infection, the drug should be continued for at least 2 weeks after the disappearance of clinical symptoms.